SALT LAKE CITY & BROOKLYN PARK, Minn.--(BUSINESS WIRE)--Hema Metrics and CHF Solutions jointly announced today that the Hema Metrics Crit-Line technology is now available in the Aquadex FlexFlow device manufactured by CHF Solutions, Inc.
The Aquadex FlexFlow is used to deliver Aquapheresis™ therapy, a safe, predictable, and effective method to remove excess salt and water from patients with fluid overload. Recently elevated in national treatment guidelines, Aquapheresis is available in over 250 medical centers and outpatient clinics worldwide and more than 22,000 patients have received this therapy to date.
The integrated Crit-Line technology, called CRIT-SAT™, allows for the non-invasive measurement of hematocrit and oxygen saturation during the Aquapheresis fluid removal process. This additional information provides an early window on each individual patient’s hemodynamic response and helps ensure the most appropriate fluid removal is achieved.
“Hematocrit monitoring with Aquapheresis provides enhanced peace-of-mind and further empowers healthcare professionals in their continuing efforts to achieve the guideline-directed treatment goal of euvolemia in fluid overloaded patients,” said Dave Springer, President and CEO of CHF Solutions.
“Hema Metrics is pleased to have joined forces with CHF Solutions,” said Patrick Moriarty, President and CEO of Hema Metrics. “We have always believed the Crit-Line technology could be very useful in the treatment of patients with fluid overload. Having the Crit-Line technology more readily available in the hospital setting will open more markets for Hema Metrics.”
About Hema Metrics LLC
Hema Metrics LLC provides diagnostic products for the hemodialysis market. Hema Metrics manufactures, markets and distributes the “CRIT-LINE®” system. The monitoring and diagnostic capability of the CRIT-LINE® technology provides better clinical outcomes and lower overall costs and improved quality of life for dialysis patients. For more information, visit www.hemametrics.com
About CHF Solutions, Inc.
CHF Solutions, based in Brooklyn Park, Minn., is a privately held manufacturer of medical devices for cardiac care. The company’s mission is to provide medical practitioners with innovative and practical solutions that enable the treatment of patients with unmet clinical needs. For more information, go to www.chfsolutions.com
Contact:
Hema Metrics LLC Patrick Moriarty, 801-451-9000 Ext. 103 President/CEO pmoriarty@hemametrics.com or CHF Solutions Inc. Dave Springer, 763-463-4600 President/CEO dspringer@chfsolutions.com
